600535:SHA
Tasly Pharmaceutical Group Co Ltd
CNÂ¥14.04
arrow_downward
-0.35%(-0.050) 1D
Okt 16, 3:00:00 PM GMT+8 · CNY
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 600535...
Buksan
CNÂ¥14.18
Mataas
CNÂ¥14.35
Mababa
CNÂ¥13.92
Mkt. cap
20.98B
Avg. na dami
11.45M
Dami
15.72M
Dividend
2.42%
Bawat tatlong buwang dividend
CNÂ¥0.09
Petsa ng ex-dividend
May 29, 2026
P/E ratio
17.15
Mataas nang 52-wk
CNÂ¥16.24
Mababa nang 52-wk
CNÂ¥12.90
EPS
CNÂ¥0.82
Mga natitirang share
1.51B
Bilang ng mga empleyado
11K
Buksan
CNÂ¥14.18
Mataas
CNÂ¥14.35
Mababa
CNÂ¥13.92
Mkt. cap
20.98B
Avg. na dami
11.45M
Dami
15.72M
Dividend
2.42%
Bawat tatlong buwang dividend
CNÂ¥0.09
Petsa ng ex-dividend
May 29, 2026
P/E ratio
17.15
Mataas nang 52-wk
CNÂ¥16.24
Mababa nang 52-wk
CNÂ¥12.90
EPS
CNÂ¥0.82
Mga natitirang share
1.51B
Bilang ng mga empleyado
11K
Mga kaugnay na stock
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
FXEmpire
·
13 oras ang nakalipas
Nasdaq Index: AI Selloff Deepens as Chips and CoreWeave Break
investingLive
·
12 oras ang nakalipas
S&P 500 analysis and forecast after the "AI bubble" panic
Bloomberg.com
·
6 araw ang nakalipas
S&P 500 Wavers as Earnings Bets Offset Chip Rout: Markets Wrap
MarketWatch
·
1 buwan ang nakalipas
The S&P 500 keeps climbing on days when stocks broadly struggle. Here’s what’s going on.
Profile
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
Tungkol sa Tasly Pharmaceutical Group Co Ltd